💊
Arexvy
recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E
Respiratoriska syncytialvirusinfektioner
✅ Auktoriserad
✅
Inga aktiva aviseringar
Denna medicin har inga pågående brister, säkerhetsbrev eller återkallelser.
Vad det används till
Arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 18 years of age and older. The use of this vaccine should be in accordance with official recommendations.
⚠️ Patientsäkerhet
No
Officiell EMA-sida
https://www.ema.europa.eu/en/medicines/human/EPAR/arexvy